Trials / Unknown
UnknownNCT04722211
Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Professor Lu Neurological Clinic · Academic / Other
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This RCT study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 or placebo intervention for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.
Detailed description
This RCT study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 or placebo intervention for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | PS128 | daily ingestion of 2 capsules of Lactobacillus plantarum PS128 (\>10 billion CFU/capsule) |
| DIETARY_SUPPLEMENT | placebo | daily ingestion of 2 capsules which only contained 425 ± 25 mg microcrystalline cellulose |
Timeline
- Start date
- 2020-07-06
- Primary completion
- 2022-12-31
- Completion
- 2023-06-30
- First posted
- 2021-01-25
- Last updated
- 2021-01-25
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04722211. Inclusion in this directory is not an endorsement.